干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
干细胞之家 - 中国干细胞行业门户第一站 干细胞之家论坛 干细胞行业新闻 Bypassing Stem Cells, Scientists Make Neurons Direct ...
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 12977|回复: 3
go

Bypassing Stem Cells, Scientists Make Neurons Directly from Human Skin [复制链接]

Rank: 4

积分
2555 
威望
2555  
包包
600  

优秀会员

楼主
发表于 2011-8-7 12:12 |只看该作者 |倒序浏览 |打印
    Researchers have come up with a recipe for making functional neurons directly from human skin cells, including those taken from patients with Alzheimer's disease. The new method may offer a critical short cut for generating neurons for replacement therapies of the future, according to research published in the August 5th issue of the journal Cell, a Cell Press publication. Already, the converted neurons are beginning to yield insights into what goes wrong in the Alzheimer's brain and how diseased neurons might respond to treatment.' R" d/ l* {. [7 s7 ~5 w$ M
    In earlier approaches to generate neurons from skin cells, those adult cells first had to be returned to an embryonic stem cell state. Those cells, called induced pluripotent stem (iPS) cells, are hard to come by -- less than one percent of cells are typically reprogrammed successfully. In addition, the entire process is time-consuming, requiring months to coax cells into iPS cells and then stimulate them to become neurons.
$ R+ K- F: j. H- Z    "iPS cells are exciting given the limits on cloning and embryonic stem cells, but it is still a roundabout and lengthy process if the goal is to take patient cells or normal cells and use them as replacement cells," said Asa Abeliovich of Columbia University, senior author of this study.# Q2 M+ w9 G% W" J6 ]+ E
    Not only are there efficiency issues, there is also an increasing concern about the stability of iPS cells, he said. Their ability to grow and produce any cell type makes them a cancer risk. Moreover, the cells may have limited use as models for understanding disease states because the processes used to derive them "may erase or overwhelm" the natural biology of the cells.
1 I6 d$ S0 P0 L" b/ A) h, r    To get around these potential pitfalls, Abeliovich's team started with known transcriptional regulators and, through a process of trial and error, identified a cocktail of factors that could turn human skin cells into neurons. While the process was not initially very efficient, they refined the protocol, ultimately converting about 50 percent of the cells.
# p% ^4 H6 z6 m$ r. o7 u    "It is a huge leap over the iPS-based process," he said. It is also more efficient than a similar method recently developed by another group.
$ o& T% M5 M% S5 {6 tWhen studied in a dish, the neurons derived from healthy skin cells could fire and receive signals, just like normal neurons. What's more, when placed into the brains of developing mice, the converted cells were able to connect up to the existing circuitry. "They really are neurons," Abeliovich said.& r4 L5 j" o" f
    The method can also produce neurons from the skin cells of patients with a rare familial form of Alzheimer's disease (AD). The AD neurons superficially looked normal, but upon closer inspection, Abeliovich's team saw abnormalities in the processing of amyloid precursor protein, the source for the amyloid plaques that riddle the brains of those with Alzheimer's disease. The neurons also showed more general differences in the way proteins inside the cell move around.0 ]& r$ b  m* P( S- u4 Q: |/ v! S
    Abeliovich says that to really understand what goes wrong in Alzheimer's disease it will be important to look at what is happening in living human neurons. Earlier studies have been limited to exploring the consequences of the Alzheimer's mutations in tumor cells, skin cells or in mouse models of the disease.
5 J' P4 n* X! B9 U  N6 }' \9 h    Potentially the most exciting use of these Alzheimer's neurons will be for testing new drug candidates. Abeliovich notes that when the cells were treated with one existing candidate drug that reduces beta amyloid production, the protein 'trafficking' problem actually worsened, raising caution about that particular treatment. Going forward, his group plans to study neurons derived from skin cells from patients with the more common, sporadic forms of Alzheimer's disease.: \, s" |: E' j3 f2 F
    "Sporadic disease accounts for 99 percent of cases and no one really knows if it is similar or different from the simpler genetic forms," Abeliovich said. "It's not a done deal that we'll be able to come up with answers, but at least we can now ask the question. In that sense, this is the tip of the iceberg."
已有 1 人评分威望 包包 收起 理由
细胞海洋 + 2 + 10 极好资料

总评分: 威望 + 2  包包 + 10   查看全部评分

Rank: 4

积分
2555 
威望
2555  
包包
600  

优秀会员

沙发
发表于 2011-8-7 12:20 |只看该作者

Rank: 4

积分
2555 
威望
2555  
包包
600  

优秀会员

藤椅
发表于 2011-8-7 12:20 |只看该作者
附件: 你需要登录才可以下载或查看附件。没有帐号?注册

Rank: 4

积分
2555 
威望
2555  
包包
600  

优秀会员

板凳
发表于 2011-8-7 12:21 |只看该作者
干细胞之家微信公众号
阿尔茨海默病已经成欧美仅次于癌症的第二大忧患作者:医药经济报 来源:医药经济报 2011-8-5 11:04:45 7 _& S( K7 ~: C) n9 g
- P, G& f9 H* U) E! ~' f7 E

4 @  ^6 I4 W' k& D" D7 }# j. [/ u3 v+ x2 h3 p# S/ K) D
(图片来源于网络)5 b4 W& w! O$ o+ p5 _# `
% I. f& i7 S# r# M
7月20日,在巴黎举行的阿尔茨海默病协会国际会议(AAIC2011)上,由哈佛公共卫生学院(HarvardSchoolofPublicHealth)公布的一份调查报告显示,在欧美主要城市人群中,阿尔茨海默病是仅次于癌症的第二大忧患,绝大多数的人一旦发现有记忆力丧失和混乱的症状就应该去看医生或让自己的亲人前去接受诊断。) P# K  _: {. y" @5 I( g
5 C5 L$ C1 G/ A2 U. i
参与调查的Alzheimer Europe执行总监Jean Georges表示:“这项调查旨在宣传重视阿尔茨海默病研究的重要意义,并让人们了解到早期诊断已经纳入到英格兰、法国、挪威和苏格兰的全国痴呆症计划中。在欧洲,我们仍在不断鼓励大家要敢于否定医学从业人员的判断,因为他们中有些人认为早期诊断和目前的治疗都是没有价值的。我们也希望民意调查能显示出人们对接受诊断的积极性以及对抗这种疾病的价值。”$ b( V# Q* y: _$ L6 B! G
8 {% [' \. p' @2 W2 n$ F- r
AAIC2011上公布的数据基于哈佛公共卫生学院在5个国家进行的一份调查。该调查得到了拜耳公司(Bayer)提供给Alzheimer Europe的资金支持。共有2678名来自法国(n=529)、德国(n=499)、波兰(n=509)、西班牙(n=502)和美国(n=639)的18岁或以上成年人在2011年2月接受了电话采访。
4 {9 L+ a2 u/ O7 z
. D/ `  H' C+ {阿尔茨海默病协会首席医疗和科学官WilliamThies博士表示:“《2010年世界阿尔茨海默病报告》显示,阿尔茨海默病是21世纪最重大的社会健康问题。很大一部分人的生活将因为阿尔茨海默病和痴呆症而有所改变,他们的家人以及整个国家都将承受惊人的经济负担,这些都让阿尔茨海默病成为当代最具代表性的疾病。但是,如果各国政府立即行动起来,对全国性研究和护理策略适当加大投入,那么阿尔茨海默病以及痴呆症的影响是可以得到控制的。”
( F: q: ]6 L9 K! w
# w1 K; J1 f; r0 a2 M许多受访者(27~63%)认为目前有能减缓阿尔茨海默病恶化并缓解这种病症状的有效的医学或药物治疗。38~59%的人认为目前有可靠的阿尔茨海默病检验方法可以判断出某个人是否是阿尔茨海默病早期患者(且不论这些说法是否正确)。受访者对政府加大阿尔茨海默病新疗法的研发投入表示强烈支持,各国的支持率分别为:82.6%(法国)、68.2%(德国)、74.7%(波兰)、83%(西班牙)和67.4%(美国)。4 i( Y5 j4 V9 Z- a# N& d

9 W6 y% k9 h* ~% X哈佛公共卫生学院卫生政策和政策分析教授、理学博士RobertBlendon表示:“很多人对治疗替代方案和医疗检验的可能性寄予厚望。医生要向患者说明哪些治疗和检验方法行得通或哪些行不通,这一点非常重要。”
5 _* ]% L# h- Q% W- u
2 D- x4 e! F0 i4 U; y4 c; _0 z对于调查结果,Jean Georges认为,调查中受访者所表露出来的焦虑和担忧证明了公众希望阿尔茨海默病问题得到解决并最终被消除的迫切性。各国政府应遵从民众们所表达出来的意愿,加大对阿尔茨海默病的研究投入。此外,对调查中受访者所表达出的对接受诊断的积极性应该加以鼓励,但提高公共教育也是必须的。需要摒弃最可靠的阿尔茨海默病早期检验和有效治疗可能无法实现的臆断,并让大家认识到在缺少有效治疗措施的情况下寻求诊断也是合理的。(生物谷 Bioon.com)
8 v8 u+ b+ i& z1 L& u+ v2 T( q9 k8 N
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2025-6-9 03:33

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.